Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 5, 2006, Pages 902-913

  López, Natalia ^a   Díez, Javier ^a,b   Fortuño, María Antonia ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adult cardiomyocytes; Angiotensinogen; Cardiac hypertrophy cardiotrophin 1; Hypertension; Myofibrils; Sarcomere; STATs

Indexed keywords

ALPHA ACTIN; ANGIOTENSINOGEN; CARDIOTROPHIN 1; CONTRACTILE PROTEIN; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MESSENGER RNA; MYOSIN LIGHT CHAIN; PROTEIN C FOS; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL GROWTH; CELL ISOLATION; CELL SIZE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEREDITARY HYPERTENSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CONTRACTILE PROTEINS; CYTOKINES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, INBRED BB; RATS, INBRED SHR; SIGNAL TRANSDUCTION;

RATTUS NORVEGICUS;

EID: 33750335041     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.433     Document Type: Article

References (42)

1. Fedak P.W., Verma S., Weisel R.D., and Li R.K. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc. Pathol. 14 (2005) 1-11
2. Hunter J.J., and Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341 (1999) 1276-1283
3. Lips D.J., deWindt L.J., van Kraaij D.J., and Doevendans P.A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24 (2003) 883-896
4. Kunisada K., Tone E., Fujio Y., Matsui H., Yamauchi-Takihara K., and Kishimoto T. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98 (1998) 346-352
5. Pemberton C.J., Raudsepp S.D., Yandle T.G., Cameron V.A., and Richards A.M. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res. 68 1 (2005) 109-117
6. Lopez B., Gonzalez A., Lasarte J.J., Sarobe P., Borras F., Diaz A., et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?. J. Hypertens 23 (2005) 625-632
7. Pennica D., Shaw K.J., Swanson T.A., Moore M.W., Shelton D.L., Zioncheck K.A., et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270 (1995) 10915-10922
8. Liao Z., Brar B.K., Cai Q., Stephanou A., O'Leary R.M., Pennica D., et al. Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc. Res. 53 (2002) 902-910
9. Lopez N., Diez J., and Fortuno M.A. Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes. Cytokine 30 (2005) 282-292
10. Pennica D., King K.L., Shaw K.J., Luis E., Rullamas J., Luoh S.M., et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1142-1146
11. Railson J.E., Liao Z., Brar B.K., Buddle J.C., Pennica D., Stephanou A., et al. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes. Cytokine 17 (2002) 243-253
12. Wollert K.C., Taga T., Saito M., Narazaki M., Kishimoto T., Glembotski C.C., et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem. 271 (1996) 9535-9545
13. Jin H., Yang R., Keller G.A., Ryan A., Ko A., Finkle D., et al. In vivo effects of cardiotrophin-1. Cytokine 8 (1996) 920-926
14. Ishikawa M., Saito Y., Miyamoto Y., Harada M., Kuwahara K., Ogawa E., et al. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J. Hypertens 17 (1999) 807-816
15. Gonzalez A., López B., Martín-Raymondi D., Lozano E., Varo N., Barba J., et al. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J. Hypertens 23 (2005) 2293-2300
16. Arrell D.K., Neverova I., Fraser H., Marban E., and Van Eyk J.E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. 89 (2001) 480-487
17. Fukuzawa J., Booz G.W., Hunt R.A., Shimizu N., Karoor V., Baker K.M., et al. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy. Hypertension 35 (2000) 1191-1196
18. Takahashi N., Saito Y., Kuwahara K., Harada M., Tanimoto K., Nakagawa Y., et al. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J. Mol. Cell Cardiol. 38 (2005) 185-192
19. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., and Olson E.N. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20 (2001) 2757-2767
20. Song H., Jin X., and Lin J. Stat3 upregulates MEK5 expression in human breast cancer cells. Oncogene 23 (2004) 8301-8309
21. Bell D., Kelso E.J., Argent C.C., Lee G.R., Allen A.R., and McDermott B.J. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Cardiovasc. Pathol. 13 (2004) 71-78
22. Onodera T., Tamura T., Said S., McCune S.A., and Gerdes A.M. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32 (1998) 753-757
23. Kumar C.C., Cribbs L., Delaney P., Chien K.R., and Siddiqui M.A. Heart myosin light chain 2 gene. Nucleotide sequence of full length cDNA and expression in normal and hypertensive rat. J. Biol. Chem. 261 (1986) 2866-2872
24. Kumar C., Saidapet C., Delaney P., Mendola C., and Siddiqui M.A. Expression of ventricular-type myosin light chain messenger RNA in spontaneously hypertensive rat atria. Circ. Res. 62 (1988) 1093-1097
25. Dalton G.R., Jones J.V., Levi A.J., and Levy A. Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats. J. Hypertens 18 (2000) 1297-1306
26. King K.L., Winer J., Phillips D.M., Quach J., Williams P.M., and Mather J.P. Phenylephrine, endothelin, prostaglandin F2alpha′ and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro. Endocrine 9 (1998) 45-55
27. Mathew S., Mascareno E., and Siddiqui M.A. A ternary complex of transcription factors, Nished and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy. J. Biol. Chem. 279 (2004) 41018-41027
28. Shubeita H.E., Martinson E.A., Van Bilsen M., Chien K.R., and Brown J.H. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1305-1309
29. Lee H.R., Henderson S.A., Reynolds R., Dunnmon P., Yuan D., and Chien K.R. Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J. Biol. Chem. 263 (1988) 7352-7358
30. Clement S., Chaponnier C., Gabbiani G., Pellieux C., and Pedrazzini T. Angiotensin II stimulates-skeletal actin expression in cardiomyocytes in vitro and in vivo in the absence of hypertension. Differentiation 69 (2001) 66-74
31. Munzel F., Muhlhauser U., Zimmermann W.H., Didie M., Schneiderbanger K., Schubert P., et al. Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition. Cardiovasc. Res. 68 (2005) 464-474
32. Jeong M.Y., Kinugawa K., Vinson C., and Long C.S. AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program. Circulation 111 (2005) 1645-1651
33. Patel J.R., Diffee G.M., and Moss R.L. Myosin regulatory light chain modulates the Ca2+ dependence of the kinetics of tension development in skeletal muscle fibers. Biophys. J. 70 (1996) 2333-2340
34. Sanbe A., Fewell J.G., Gulick J., Osinska H., Lorenz J., Hall D.G., et al. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J. Biol. Chem. 274 (1999) 21085-21094
35. Aoki H., Sadoshima J., and Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat. Med. 6 (2000) 183-188
36. Pan J., Fukuda K., Kodama H., Sano M., Takahashi T., Makino S., et al. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels 13 (1998) 199-208
37. Kuwahara K., Saito Y., Harada M., Ishikawa M., Ogawa E., Miyamoto Y., et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100 (1999) 1116-1124
38. Mascareno E., Dhar M., and Siddiqui M.A.Q. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. PNAS 95 (1998) 5590-5594
39. Anversa P., Levicky V., Beghi C., McDonald S.L., and Kikkawa Y. Morphometry of exercise-induced right ventricular hypertrophy in the rat. Circ. Res. 52 (1983) 57-64
40. Anversa P., Olivetti G., Melissari M., and Loud A.V. Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat. J. Mol. Cell Cardiol. 12 (1980) 781-795
41. Calderone A., Takahashi N., Izzo Jr. N.J., Thaik C.M., and Colucci W.S. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92 (1995) 2385-2390
42. Yoshihara F., Nishikimi T., Horio T., Yutani C., Nagaya N., Matsuo H., et al. Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H633-H642